Saturday, 7 November 2026European Markets

SCANA Stock Was 11.95% Up On Monday

Loading stream...

(VIANEWS) - The Market ended the session with SCANA (SCANA.OL) rising 11.95% to kr3.19 on Monday while Oslo Børs Benchmark Index_GI fell 0.73% to kr1,428.96.

SCANA's last close was kr2.85, 0.18% under its 52-week high of kr2.85.

About SCANA

Scana ASA engages in the offshore, energy, and maritime businesses in Norway, rest of European countries, America, Asia, Africa, and Oceania. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, aquaculture, oil and gas, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. Scana ASA was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. The company was founded in 1646 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, SCANA has a trailing twelve months EPS of kr0.23.

PE Ratio

SCANA has a trailing twelve months price to earnings ratio of 13.85. Meaning, the purchaser of the share is investing kr13.85 for every norwegian krone of annual earnings.

Moving Average

SCANA's value is way above its 50-day moving average of kr2.27 and way higher than its 200-day moving average of kr2.19.

Volatility

SCANA's last week, last month's, and last quarter's current intraday variation average was 1.70%, 1.28%, and 1.71%.

SCANA's highest amplitude of average volatility was 3.71% (last week), 2.53% (last month), and 1.71% (last quarter).

Sales Growth

SCANA's sales growth is 5.7% for the present quarter and 15.7% for the next.

More news about SCANA (SCANA.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com